secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2026-10-06T20:05:29+00:00
Accession:  0001104659-26-114042
Event type: regulatory
Sentiment:  positive
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4.1-flash:cloud@v2

TELA Bio regains Nasdaq minimum bid price compliance; listing matter closed
---------------------------------------------------------------------------

- Nasdaq letter dated October 5, 2026 states TELA Bio regained compliance with Nasdaq Listing Rule 5450(a)(1), the minimum bid price requirement for the Nasdaq Global Market; matter is now closed.
- Company's common stock continues to be listed and traded on the Nasdaq Global Market under the symbol 'TELA'.
- Filing signed by Heather Getz, Chief Executive Officer and Director, dated October 6, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465926114042/0001104659-26-114042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465926114042/tm2627116d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-114042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer